M. Miranda

发表

Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence

L. Haddad, B. B. de Mendonça, G. Madureira, 2019, Journal of the Endocrine Society.

International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia - data from the I-CAH registry.

M. Korbonits, S. Poyrazoglu, F. Darendeliler, 2021, European journal of endocrinology.

Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency

A. Lenzi, M. Korbonits, F. Darendeliler, 2020, Yearbook of Paediatric Endocrinology.

Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency.

A. Lenzi, M. Korbonits, F. Darendeliler, 2019, The Journal of clinical endocrinology and metabolism.

Neonatal 17‐hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening

B. Mendonca, V. Brito, G. Madureira, 2017, Clinical endocrinology.

Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency

B. Mendonca, R. Scalco, G. Madureira, 2019, Journal of the Endocrine Society.

Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.

H. Kuperman, D. Damiani, B. Mendonca, 2016, European journal of endocrinology.

Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia

J. Lewsey, M. Korbonits, S. Poyrazoglu, 2020, The Journal of clinical endocrinology and metabolism.

DEFINING THE DOSE, TYPE AND TIMING OF GLUCOCORTICOID AND MINERALOCORTICOID REPLACEMENT IN 256 CHILDREN AND ADULTS WITH CONGENITAL ADRENAL HYPERPLASIA (CAH) IN THE I-CAH REGISTRY

C. Acerini, F. Darendeliler, W. Bonfig, 2017 .

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia

H. Falhammar, V. Iotova, F. Ceccato, 2022, Endocrine.

Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years

B. Ferraz-de-Souza, B. Mendonca, R. M. Martin, 2020, Osteoporosis International.

Exploring trends in the glucocorticoid and mineralocorticoid treatment of congenital adrenal hyperplasia by analysing data from the I-CAH registry

M. Korbonits, F. Darendeliler, V. Iotova, 2019, Endocrine Abstracts.

Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.

H. Kuperman, D. Damiani, B. Mendonca, 2016, European journal of endocrinology.